Cumberland says Ifetroban improves heart function in Phase 2 Duchenne study
Cumberland reported improved heart function among Duchenne patients in a Phase 2 study of Ifetroban.
Cumberland reported improved heart function among Duchenne patients in a Phase 2 study of Ifetroban.